Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study
H Aardema, PN Panday, M Wessels… - International journal of …, 2017 - Elsevier
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study
H Aardema, PN Panday, M Wessels… - International …, 2017 - pubmed.ncbi.nlm.nih.gov
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: A prospective observational study
H Aardema, PN Panday, M Wessels… - International journal …, 2017 - research.rug.nl
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study
H Aardema, PN Panday, M Wessels… - International Journal …, 2017 - research.hanze.nl
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study.
H Aardema, PN Panday, M Wessels, K Hateren… - 2017 - cabidigitallibrary.org
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study
H Aardema, PN Panday, M Wessels… - International Journal of …, 2017 - infona.pl
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study.
H Aardema, N Panday, M Wessels… - International Journal …, 2017 - europepmc.org
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study
H Aardema, PN Panday, M Wessels… - International Journal …, 2017 - research.hanze.nl
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …